Adonis Semax – Research Peptide (RUO)
£27.99 mg inc. VAT
Semax 10mg – Research Peptide
Semax is a synthetic peptide derivative based on adrenocorticotropic hormone (ACTH) fragment structure and has been studied in laboratory settings for its interaction with neurobiological signalling pathways, peptide-mediated communication, and regulatory processes associated with central nervous system research.
Scientific interest in Semax focuses on how short peptide compounds may influence molecular signalling related to neuronal activity, neurotrophic factor expression, and adaptive responses within controlled experimental models.
Product Information
| Product Name | Semax |
| Content | 10mg Lyophilized Peptide |
| Form | Freeze-dried powder |
| Purity | >98% (HPLC Tested) |
| Storage | Store at −20°C (long-term recommended) |
| Stability | Stable under laboratory storage conditions |
| Application | Scientific and laboratory research use only |
Overview
Semax is commonly investigated in experimental research involving peptide-based neuroregulation, central nervous system signalling, and adaptive cellular communication. As a modified peptide derived from an ACTH fragment, it has attracted interest in studies exploring how peptide signals interact with neuronal systems and regulatory pathways.
Laboratory models often examine Semax in relation to peptide-mediated signalling mechanisms linked to neural tissue response, neurochemical regulation, and broader central nervous system research applications. These investigations aim to better understand how short peptides may influence complex biological communication networks in controlled settings.
Potential Research Applications
- Neuropeptide signalling pathway research
- Central nervous system communication studies
- Neurotrophic factor expression investigations
- Peptide-based regulatory mechanism research
- Neuronal adaptation and stress response models
- Experimental studies involving ACTH-derived peptide signalling
Scientific Background
Semax is a synthetic peptide developed from a fragment of adrenocorticotropic hormone, modified to explore biological activity beyond the parent hormone’s conventional signalling profile. In research settings, peptides of this class are studied for their ability to participate in molecular communication within neural and regulatory systems.
Experimental investigations have examined how peptide compounds such as Semax may interact with pathways involved in neuronal signalling, neurotrophic regulation, and adaptive biological responses. These areas of study are relevant for understanding the broader role of short peptides in central nervous system research.
Ongoing scientific work continues to explore how Semax contributes to peptide signalling research, neuronal communication models, and the study of regulatory pathways within controlled laboratory environments.
Safety and Handling
This compound is supplied strictly for laboratory research purposes. Handling should be performed by qualified personnel using appropriate laboratory safety procedures and controlled research conditions.
Use outside intended research applications is not recommended.
Disclaimer
Semax is supplied strictly for research use only.
- Not for human consumption
- Not for medical or veterinary use
- Information provided is for educational and scientific reference purposes only
| Weight | 10mg |
|---|---|
| Purity | Purity ≥98% (HPLC). COA available on request. Batch-tracked for traceability. |
| Compliance | RUO only. Not for human or veterinary use. No dosing or administration guidance provided. |
| Type | “Vial”, “Spray” |
You may also like…
Adonis DSIP (Delta Sleep-Inducing Peptide) – Research Peptide (RUO)
From £20.79 inc. VATMulti Buy Savings
